The impact of COVID-19 on TB: a review of the data.
Int J Tuberc Lung Dis
; 25(6): 436-446, 2021 06 01.
Article
in English
| MEDLINE | ID: covidwho-1248353
ABSTRACT
Early in the COVID-19 pandemic, models predicted hundreds of thousands of additional TB deaths as a result of health service disruption. To date, empirical evidence on the effects of COVID-19 on TB outcomes has been limited. Here we summarise the evidence available at a country level, identifying broad mechanisms by which COVID-19 may modify TB burden and mitigation efforts. From the data, it is clear that there have been substantial disruptions to TB health services and an increase in vulnerability to TB. Evidence for changes in Mycobacterium tuberculosis transmission is limited, and it remains unclear how the resources required and available for the TB response have changed. To advocate for additional funding to mitigate the impact of COVID-19 on the global TB burden, and to efficiently allocate resources for the TB response, requires a significant improvement in the TB data available.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
/
Mycobacterium tuberculosis
Type of study:
Experimental Studies
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Int J Tuberc Lung Dis
Year:
2021
Document Type:
Article
Affiliation country:
Ijtld.21.0148
Similar
MEDLINE
...
LILACS
LIS